iBio, Inc. (IBIO) Closes $4.2 Million Public Offering and Terminates at-the-Market Offering
4/29/2013 10:12:08 AM
More...
|
iBio, Inc. (IBIO) Prices $4.2 Million Public Offering
4/23/2013 10:01:08 AM
More...
|
iBio, Inc. (IBIO) Announces Proposed Public Offering
4/23/2013 9:23:35 AM
More...
|
iBio, Inc. (IBIO) Passes Commercial Technology Transfer Milestone
4/22/2013 11:11:19 AM
More...
|
iBio, Inc. (IBIO) Receives Notice From NYSE MKT Staff That Company Currently is Not in Compliance With an Additional Continued Listing Standard
4/22/2013 11:06:28 AM
More...
|
iBio, Inc. (IBIO) Selects Proprietary Recombinant C1 Inhibitor for Clinical Development
3/26/2013 9:40:01 AM
More...
|
iBio, Inc. (IBIO) Adds to iBioModulator Portfolio and Product Pipeline
3/13/2013 9:50:09 AM
More...
|
iBio, Inc. (IBIO) Receives Anticipated Notice From NYSE MKT That Company is Below Certain Continued Listing Standards
3/5/2013 1:12:12 PM
More...
|
iBio, Inc. (IBIO) Adds New Therapeutic Antibody to Its Pipeline
3/4/2013 10:08:46 AM
More...
|
iBio, Inc. (IBIO) and Caliber Biotherapeutics Establish License and Collaboration Relationship
2/19/2013 10:21:52 AM
More...
|
|